Excessive RNA Editing Linked to Myeloma Progression, Treatment Resistance, Study Suggests
Abnormally high production of an RNA editing enzyme called…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
FDA Grants Poseida’s P-BCMA-101 RMAT Status for Treatment of Multiple Myeloma
The U.S. Food and Drug Administration (FDA)Â …
FDA Clears Way for Trials of FOR46 in Late-stage Multiple Myeloma, Prostate Cancer
The U.S. Food and Drug Administration has allowed Fortis…
FDA Approves Empliciti Combination for Relapsed or Refractory Multiple Myeloma
The U.S. Food and Drug Administration has approved…
Darzalex Add-on Delays Disease Progression or Death in Newly Diagnosed Multiple Myeloma, Phase 3 Trial Shows
Treatment with Darzalex (daratumumab) plus standard Revlimid (…
Myeloma Crowd Launches Online Tool to Help Patients Find Treatment Options, Contribute to Research
Myeloma Crowd has launched an online tool called…
